BioStrand (a subsidiary of IPA)

IPA (ImmunoPrecise Antibodies) Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSᵃⁱ™ Technology The 2024 Impact Award, sponsored by InterSystems, acknowledges BioStrand’s innovative LENSᵃⁱ technology, selected from over 1,000 client projects for its remarkable contributions. The selection committee, chaired by Professor Roberto Zicari, identified BioStrand’s work based on three key criteria: makes a significant difference, breaks new ground and sets an example. Tune in to today's Main Stage live to see the award presentation from 10:30-11:00am ET : https://lnkd.in/dJ3uhRyc See the full release: https://lnkd.in/evKm9qpQ #VectorSearch #DrugDiscovery #BioTech #Antibodies #LENSai

High throughput in silico mAb #EpitopeBinning with proven wet lab validation   Our case study proves LENSᵃⁱ™ in silico epitope binning delivers near-perfect agreement with wet lab binning.    Key Benefits: - Proven: Matches wet lab binning methods with high accuracy. - Scalable for High-Throughput Analysis: Results within hours for small subsets to 2 weeks for >5k #antibodies. - Fast and Efficient: Designed to reduce time and costs   Read the full case study. https://lnkd.in/efWW6K9e #InSilico #mAb #DrugDisccovery

Thank you to everyone who joined our IPA TECHday to explore how advanced AI is reshaping #antibodydiscovery! Last Friday, we wrapped up an inspiring IPA TECHday in Boston at InterSystems' global headquarters. The day featured impactful sessions, starting with Dr. Dirk Van Hyfte’s opening remarks. We also showcased a live demo of BioStrand LENSᵃⁱ™ solutions, covering NGS data analysis, hit expansion, epitope mapping, and more—highlighting how our AI tools address today’s complex #biotherapeutic challenges. Dr. Shuji Sato further enriched the discussions by exploring the fusion of in silico and wet lab services, focusing on Rabbit discovery and its scalability. The day concluded with an engaging fireside chat featuring Jeff Fried and Dirk Van Hyfte, diving into #multimodal data integration for rational drug design and the role of AI and vector search. Couldn’t attend? Let’s connect: https://lnkd.in/ehXUPWUj #DrugDiscovery #BioTech

IPA TECHday is now on at InterSystems' HQ in Boston! We’re kicking off with Dr. Dirk Van Hyfte’s session on demos showcasing our universal foundation AI model in action. The day is all about exploring real solutions and breakthroughs in #biotherapeutics. #IPATECHday #BioTech IPA (ImmunoPrecise Antibodies)

Live from booth 7 at AI Driven Drug Discovery Summit in Boston! Frédéric Chabot, Dirk Van Hyfte, and Shuji Sato are here exploring how AI is shaping rational drug discovery. Come meet the team and join the conversation! #AIDDD #DrugDiscovery

We're LIVE at the AI Driven Drug Discovery Summit in Boston! We’re excited to kick off this transformative event with an exclusive TECHbite Social, hosted by IPA (ImmunoPrecise Antibodies) and BioStrand, bringing together innovators and industry experts for an evening of insights, connections, and collaboration. When: November 13, 6-8 PM Where: Alma Gaucha, Boston, MA Let’s talk about the future of #antibodydiscovery and AI-driven #innovations. Don’t miss out on the chance to network over drinks, apps, and big ideas. Limited space available! RSVP today to secure your spot. https://lnkd.in/e7Y4Z_Fx #AIDrugDiscovery #AI #DrugDevelopment

Countdown to TECHDAY on Friday, November 15, 2024, from 9:00 a.m. to 12:30 p.m. EST in Cambridge, MA. This exclusive, interactive event is designed for real-time insights and live demos of the latest in biotech innovation. Showcasing LENSᵃⁱ™ our AI-driven drug discovery platform —capable of screening the human proteome, delivering 5 months' worth of data in just 2 minutes—as well as data-powered antibody development, we're set for dynamic discussions and deep dives with top minds in the field. Get ready to uncover transformative solutions and shape the future of therapeutics together. Discover insights that give you a competitive edge in this rapidly evolving field! Limited spots remain: Contact Jennifer K. Zimmons, PhD, MBA, at Quantum Media to reserve your spot: jen@quantum-corp.com #TechBio #mAb #Antibodies #DrugDiscovery #ArtificialIntelligence InterSystems Quantum Media Group, LLC Professor Ari Zoldan Jennifer K. Zimmons, Ph.D.

Mark your calendar for an exclusive event! We are hosting #TECHDAY on Friday, November 15, from 9:00 a.m. to 12:30 p.m. EST in Cambridge, MA. This event offers a deep dive into groundbreaking advancements in AI-driven biologics, design innovations, and strategic tech developments—all driving the future of #therapeuticdiscovery. Highlights: - Dirk Van Hyfte will introduce LENSᵃⁱ™, BioStrand’s innovative platform accelerating #drugdiscovery with AI and multi-omics integration. - Shuji Sato presents IPA (ImmunoPrecise Antibodies)’s B Cell Discovery Platform, leveraging advanced AI and NGS workflows for efficient hit expansion. - Fireside Chat with Dirk Van Hyfte and Jeff Fried from InterSystems on seamless #dataintegration for faster, more accurate #antibodydiscovery. See full details: https://lnkd.in/ebMkAPrC To reserve your seat, contact Jennifer K. Zimmons, Ph.D., at: jen@quantum-corp.com.

How can integrating #multiomics data reveal deeper insights? Multi-omics approaches combine genomics, proteomics, and other data layers to map complex biological interactions. Our latest article walks through strategies to unify these datasets, supporting a more comprehensive understanding of molecular systems and advancing research applications. Explore the full article: https://lnkd.in/euDChVyA #BioStrandBlogs #Omics #DataIntegration #Bioinformatics

#AI is no longer just a buzzword in #lifesciences.   At BioTechX 2024, it was clear how AI is transforming clinical trials, personalized medicine, and molecular engineering. It’s not just about speeding things up—it’s about driving better outcomes across the board.   However, a key challenge remains: aligning biological insights with AI applications and seamlessly integrating complex datasets to unlock even greater potential.   Curious how BioStrand can help here? Check out the full blog: https://lnkd.in/emssNXzu #BioStrandBlogs #BioTechX2024 #DataIntegration